Continue to Site

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

MassDevice Q&A

MassDevice Q&A: GenomeQuest CEO Ron Ranauro

By Leave a Comment

Ron Ranauro spent the better part of two decades in the computer industry, watching as the personal computer and the Internet transformed the business. It’s growing maturity coincided with early efforts to sequence the human genome, leading Ranauro in the late 1990s to apply his computing chops to the life science scene.

MassDevice spoke with Ranauro as GenomeQuest launched an application programming interface that allows developers to customize apps for their labs’ research programs. We asked him about the API, what sets his venture apart from other sequencing data management firms (hint: it’s in the clouds) and got his take on the ethical implications of widespread access to genome sequencing technology.

MassDevice Q&A: PatientKeeper CEO Paul Brient

By Leave a Comment

Paul Brient, the president and CEO of PatientKeeper Inc., has spent 20 years in the healthcare IT trenches, first with the physician practice management software start-up he founded and ran, BCS Inc. After stints at McKesson Corp. (NYSE:MCK), HPR Inc. and The Boston Consulting Group, he joined PatientKeeper in 2002.

MassDevice Q&A: Myomo CEO Steve Kelly

By Leave a Comment

Steve Kelly’s spent three decades watching new technology that originated in consumer electronics wreak havoc on well-established industries. The CEO of Myomo Inc. bore witness as new technologies redefined the home computing market in the 1980s, the telecom space in the 1990s and the changes voice-over-IP technology brought to telephony in the last decade.

Kelly sees a similar wave heading for the shores of the medical device industry. MassDevice spoke with him to hear his take on where the sector is headed and why.

MassDevice Q&A: CeQur CEO Jim Peterson

By Leave a Comment

Jim Peterson spent the better part of 20 years helping to improve the quality of the world’s blood supply at Haemonetics Corp. (NYSE:HAE), where he was CEO from 1998 to 2003. And while he was passionate about the importance of that work, his new role as chief executive for CeQur Ltd. might be even closer to his heart.

Peterson spoke with MassDevice just before giving a presentation on the patch-like device CeQur is developing for insulin delivery at the OneMedPlace Finance Forum in San Francisco Jan. 13. He told us about the personal connection he feels to his current work, which stems from the fact that his daughter has diabetes, and why he sees Montreux, Switzerland-based CeQur’s device as a potential market leader.

MassDevice Q&A: Covidien medical devices president José Almeida

By Leave a Comment

José Almeida knows what it takes to succeed. The native of Brazil, a mechanical engineer by training, put down roots in the U.S. 20 years ago and never looked back.

Since then he’s worked his way up the corporate ladder at firms including Acufex Microsurgical, Johnson & Johnson (NYSE:JNJ), Greatbatch Technologies and Tyco Healthcare. When the latter spun out into Covidien in late June, 2007, Almeida had been in his current role for a year already after spending the better part of 12 years with the company.

Researchers take on the FDA

By Leave a Comment

It’s not often that a few doctors ensconced in the ivy towers of academia can get a lumbering dinosaur like the Food & Drug Administration to turn on a dime, let alone during the week between Christmas and the new year.

But that’s exactly what University of California at San Francisco researchers Sanket S. Dhruva, Lisa Bero and Rita Redberg did after the Journal of the American Medical Assn. published their paper “Strength of Study Evidence Examined by the FDA in Premarket Approval of Cardiovascular Devices.”

MassDevice Q&A: Serica Technologies CEO Greg Altman

By

Thirteen years ago Greg Altman, president and CEO of Serica Technologies Inc., blew out his knee playing football. After reconstructive surgery on his ruptured anterior cruciate ligament, the former All-American at Tufts University found the rehabilitation process so challenging that he set out to develop an alternative.

MassDevice Q&A: Advertising executive Bruce Lehman

By Leave a Comment

Bruce Lehman’s been in the advertising game since the late 1970s, but the principal at Lehman Millet, a Boston-based marketing and communications agency, has been focused on the medical device and diagnostics industry solely since the 1990s, making it a powerful player in the industry despite its relatively small size.

Today, Lehman Millet‘s client mix includes biotechnology, biomaterials and specialty pharmaceutical firms, along with its core medical device customers. MassDevice: spoke with Lehman, 59, about an ever-present question: “How, exactly, do you market a medical device?”

MassDevice Q&A: Thermo Fisher Scientific CEO Marc Casper

By Leave a Comment

To outside observers, Marijn Dekkers’ departure from the corner office at Thermo Fisher Scientific (NYSE:TMO) might have seemed abrupt. After a seven-year run during which he led a profound re-shaping of the laboratory equipment and supplies manufacturer (and boosted revenues from the $2 billion range to about $10.5 billion a year), Dekkers resigned as CEO of the Waltham, Mass.-based firm to take the helm at German pharma giant Bayer AG.

MassDevice Q&A: GE Healthcare’s David Freeman

By Leave a Comment

It’s no secret that wireless technology is in a growth spurt. From WiFi cars on commuter trains to the omnipresent Bluetooth and iPhone devices, as the saying goes, “There’s an app for that.”

The medical industry is no exception. Wireless medical devices are becoming more and more common, with innovations like pacemakers that can send data directly to physicians. GE Healthcare is looking to push the envelope even further, with a vision for wireless medical monitoring systems that would eliminate the rat’s nest of cables that spring up around hospital patients.

Copyright © 2024 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy